Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD4 T follicular helper cell dynamics during SIV infection
Constantinos Petrovas, … , Elias K. Haddad, Richard A. Koup
Constantinos Petrovas, … , Elias K. Haddad, Richard A. Koup
Published August 27, 2012
Citation Information: J Clin Invest. 2012;122(9):3281-3294. https://doi.org/10.1172/JCI63039.
View: Text | PDF
Research Article Article has an altmetric score of 6

CD4 T follicular helper cell dynamics during SIV infection

  • Text
  • PDF
Abstract

CD4 T follicular helper (TFH) cells interact with and stimulate the generation of antigen-specific B cells. TFH cell interaction with B cells correlates with production of SIV-specific immunoglobulins. However, the fate of TFH cells and their participation in SIV-induced antibody production is not well understood. We investigated the phenotype, function, location, and molecular signature of TFH cells in rhesus macaques. Similar to their human counterparts, TFH cells in rhesus macaques represented a heterogeneous population with respect to cytokine function. In a highly differentiated subpopulation of TFH cells, characterized by CD150lo expression, production of Th1 cytokines was compromised while IL-4 production was augmented, and cells exhibited decreased survival, cycling, and trafficking capacity. TFH cells exhibited a distinct gene profile that was markedly altered by SIV infection. TFH cells were infected by SIV; yet, in some animals, these cells actually accumulated during chronic SIV infection. Generalized immune activation and increased IL-6 production helped drive TFH differentiation during SIV infection. Accumulation of TFH cells was associated with increased frequency of activated germinal center B cells and SIV-specific antibodies. Therefore, chronic SIV does not disturb the ability of TFH cells to help B cell maturation and production of SIV-specific immunoglobulins.

Authors

Constantinos Petrovas, Takuya Yamamoto, Michael Y. Gerner, Kristin L. Boswell, Kaska Wloka, Emily C. Smith, David R. Ambrozak, Netanya G. Sandler, Katherina J. Timmer, Xiaoyong Sun, Li Pan, Amanda Poholek, Srinivas S. Rao, Jason M. Brenchley, S. Munir Alam, Georgia D. Tomaras, Mario Roederer, Daniel C. Douek, Robert A. Seder, Ronald N. Germain, Elias K. Haddad, Richard A. Koup

×

Figure 5

TFH cells are characterized by low cell cycling capacity and increased sensitivity to in vitro cell death.

Options: View larger image (or click on image) Download as PowerPoint
TFH cells are characterized by low cell cycling capacity and increased s...
(A) The schedule of the in vivo administration of BrdU and collection of LN tissues from chronic SIV-infected RMs (n = 3) as well as the percentage of Ki67hiBrdUhi cells in naive, CM, and EM CD4 T cell populations are shown. The frequency (%) of Ki67hiBrdUhi cells in CM/CD4 T cell populations, based on their expression of CCR7, PD-1, and CD150, is also shown. (B) Pooled data showing the percentage of active caspase-3+ cells in the naive and CM subpopulations from noninfected (n = 7; white bars) and chronic SIV-infected RMs (n = 13; gray bars). (C) Pooled data showing the relative frequency (%) of PD-L1lo, PD-L1dim, and PD-L1hiCD20hiCD3lo B cells in SIV– (n = 10) and chronic SIV-infected LNs (n = 10 for low percentage of TFH cells and n = 4 for high percentage of TFH cells). (B and C) In the box-and-whiskers plot, box size represents the limits of data for the second and third quartiles, with medians shown as bars. Whiskers define the minimum and maximum of the data presented. P values were calculated using the Mann-Whitney U test. *P < 0.0001. (D) The relative expression of the S1PR1 mRNA in sorted cells from acute SIV-infected (n = 3; LN tissues) and chronic SIV-infected RMs, with low percentage of TFH cells (n = 3; LN tissues) and high percentage of TFH cells (n = 7; LN tissues), is shown. The normalized CT value for CD28hiCD95hiCCR7hiPD-1lo cells was assigned a value of 1, and the fold change over this value for the populations tested is shown.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
164 readers on Mendeley
See more details